![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Stryker to Acquire Synergetics USA’s Neuro Portfolio
Stryker to Acquire Synergetics USA’s Neuro Portfolio
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GreenDollarSign.gif?t=1433864063&width=430)
February 10, 2016
Stryker has entered an agreement to acquire all of the assets associated with Synergetics USA’s neuro portfolio.
The portfolio includes the Malis generator, Spetzler Malis disposable forceps and Stryker’s existing Sonopet tips and RF generator. The Synergetics’ portfolio achieved sales in 2015 of roughly $31 million.
The transaction is expected to close in the first quarter. — Jonathon Shacat
Upcoming Events
-
21Oct